Video calls with pharmacists may cut risky drug use in older veterans

NCT ID NCT04340570

First seen Jun 24, 2026 · Last updated Jun 24, 2026

Summary

This study tested whether having a pharmacist review medications via a home video visit could improve how older Veterans use their medicines. The study included 304 Veterans who took at least five daily drugs and had two or more chronic conditions. Researchers checked for inappropriate medication use and side effects to see if the televisits made a difference.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TELEMEDICINE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • James J. Peters VA Medical Center, Bronx, NY

    The Bronx, New York, 10468-3904, United States

  • VA Bedford HealthCare System, Bedford, MA

    Bedford, Massachusetts, 01730-1114, United States

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

pharmacist-led medication management via home televisit

What this could lead to

If successful, this approach could help older adults with complex medication regimens reduce risky drug use and improve medication safety at home.

What could go wrong

This is a completed study with 304 participants, but results may not apply to non-Veteran populations or those without access to video technology.

Conditions

The condition(s) this trial relates to.

Multiple Chronic Conditions

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.